Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Mitsui Chemicals ( (JP:4183) ) just unveiled an update.
Mitsui Chemicals reported a decline in FY2025 consolidated sales revenue to ¥1,668.8 billion from ¥1,809.2 billion, with operating income before special items edging down to ¥100.0 billion. Profitability weakened mainly in Mobility Solutions and Basic & Green Materials, though ICT Solutions and Life & Healthcare Solutions showed resilience, while net income attributable to owners of the parent rose modestly to ¥34.4 billion.
Specialty chemicals domains remained the core earnings driver, offsetting part of the downturn in commodity-related businesses, as the company continued to shift its portfolio toward higher-margin areas. Capital expenditures increased to ¥162.2 billion and R&D spending also grew, underscoring continued investment in future growth despite softer volumes and pricing, while the balance sheet stayed stable with a slightly improved net D/E ratio and solid positive operating cash flow.
The most recent analyst rating on (JP:4183) stock is a Buy with a Yen2700.00 price target. To see the full list of analyst forecasts on Mitsui Chemicals stock, see the JP:4183 Stock Forecast page.
More about Mitsui Chemicals
Mitsui Chemicals, Inc. is a diversified Japanese chemical manufacturer supplying specialty chemicals, basic and green materials, and solutions for life and healthcare, mobility, and ICT markets. The group operates globally with more than 16,000 employees, focusing on value-added specialty domains while restructuring its segment classifications following recent organizational reforms.
Average Trading Volume: 3,162,482
Technical Sentiment Signal: Buy
Current Market Cap: Yen750.7B
For a thorough assessment of 4183 stock, go to TipRanks’ Stock Analysis page.